Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-FR Version v8-EN
Language French English
Date Updated 2020-03-31 2019-04-15
Drug Identification Number 02306727 02306727
Brand name PANTOPRAZOLE SODIUM FOR INJECTION PANTOPRAZOLE SODIUM FOR INJECTION
Common or Proper name PANTOPRAZOLE PANTOPRAZOLE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients PANTOPRAZOLE PANTOPRAZOLE
Strength(s) 40MG 40MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 10
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-11-12 2018-11-12
Estimated end date 2020-01-31 2019-04-22
Actual end date 2020-02-04
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Competitive BO resulting in limited supply. Closely monitoring stock at wholesalers.
Health Canada comments